TRT injection infections: separating real risk from panic

What did @adaclipsadmin actually say?

The video features an infectious disease physician, Dr. Mindy Pruitt, giving advice about infected testosterone injection sites. The core warnings: don't inject into an already-infected site because "the next day it blows up," skin bacteria are the usual culprits, and penicillin allergy claims are mostly overclaimed. She names doxycycline, Bactrim, linezolid, and clindamycin as alternatives for MRSA coverage, and flags that antibiotic resistance has eroded options over time.

These are real clinical points. The framing around "criminals next door" when you puncture skin is colorful but not medically wrong. Skin flora, particularly Staphylococcus aureus, are the dominant pathogens in injection site infections, and the advice to avoid re-injecting an infected site is sound. The penicillin allergy section is where things get genuinely useful and where some sloppy language also creeps in.

Does the science back this up?

Mostly, yes. The claim that penicillin allergy is overclaimed is one of the better-supported positions in modern infectious disease. Studies consistently show that 80 to 90 percent of patients who report penicillin allergy are not actually allergic when formally tested.

A 2019 review by Blumenthal et al. in JAMA confirmed that penicillin allergy labels persist on records despite the vast majority being either mislabeled or tolerance having developed over time. This matters clinically because patients labeled as penicillin-allergic frequently receive broader-spectrum or less effective antibiotics, which contributes to resistance. The resistance angle she raises at the end is also real. CDC surveillance data show declining susceptibility of MRSA strains to certain agents in some geographic regions, though resistance patterns vary significantly by community and hospital setting. Clindamycin resistance in community MRSA specifically has been documented in multiple studies, including Moran et al. (2006, NEJM), which remains a reference point for outpatient skin infection management.

What did they get wrong (or right)?

The antibiotic coverage claims need scrutiny. Dr. Pruitt says clindamycin "covers some MRSA, but not all." That is technically true but undersells the problem. Clindamycin resistance in community-acquired MRSA varies widely by region, running anywhere from under 10 percent to over 30 percent depending on local epidemiology. Treating a potentially serious MRSA infection with clindamycin without checking local resistance data is not best practice.

The linezolid mention is also worth flagging. Linezolid is a last-resort antibiotic reserved for serious, treatment-resistant infections. Casually naming it in the same breath as Bactrim and doxycycline in a TikTok context, without noting its limited indication or cost, is irresponsible framing even if technically accurate. These are not interchangeable options a patient should be selecting themselves.

What she got right: the core message that you should not inject into an inflamed or potentially infected site is correct and important. Injecting into an infected area risks spreading infection into deeper tissue or the bloodstream, which can escalate quickly. That warning alone is worth amplifying.

What should you actually know?

If your injection site is red, warm, swollen, or producing pus, stop injecting at that site and contact a clinician. Do not attempt to self-diagnose whether it is a sterile abscess, cellulitis, or MRSA. These require physical examination and sometimes imaging or culture. Waiting 48 hours to see if it "blows up" further is not a strategy.

On the penicillin allergy point: if you have a penicillin allergy label in your chart, it is worth discussing formal allergy testing with your provider. Carrying an inaccurate allergy label can result in you receiving less effective antibiotics if you ever develop a serious skin infection. This is a real clinical consequence, not a theoretical one.

Antibiotic selection for injection site infections is not a TikTok decision. Bactrim, doxycycline, clindamycin, and linezolid have different indications, resistance profiles, and side effect risks. If you are doing self-administered TRT injections, proper technique, sterile equipment, and site rotation are your primary defenses against infection. Talk to a prescribing clinician if you notice any signs of infection, not a comment section.

Bottom line verdict

The foundational advice here is defensible. Infectious disease physicians do say these things in clinic. But the format, a fast-cut TikTok with no dosing guidance, no mention of when to go to an emergency room, and casual naming of last-resort antibiotics, strips out the clinical context that makes this information safe. The penicillin allergy section is the most genuinely useful part. The antibiotic rundown at the end is the most potentially harmful if someone takes it as a self-treatment menu. Give credit for the core warning about not re-injecting infected sites. Push back on the idea that naming four antibiotics in 30 seconds constitutes useful guidance.